Changes

m
citations
Line 138: Line 138:  
|''CBL''
 
|''CBL''
 
|Recurrent
 
|Recurrent
|<ref name=":13" /><ref name=":33" /><ref name=":10" /><ref name=":5" />44]
+
|<ref name=":13" /><ref name=":33" /><ref name=":10" /><ref name=":5" /><ref name=":34">Gondek LP, Dunbar AJ, Szpurka H, McDevitt MA, Maciejewski JP. SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD. PLoS One 2007;2:e1225. [https://www.ncbi.nlm.nih.gov/pubmed/18030353]</ref>
 
|-
 
|-
 
|MPN
 
|MPN
Line 145: Line 145:  
|
 
|
 
|Recurrent
 
|Recurrent
|[40, 55, 56]
+
|<ref>Singh NR, Morris CM, Koleth M, Wong K, Ward CM, Stevenson WS. Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing disease. Mol Cytogenet 2013;6:59.[https://www.ncbi.nlm.nih.gov/pubmed/24341401]</ref>56]
 
|-
 
|-
 
|
 
|
Line 159: Line 159:  
|''JAK2''
 
|''JAK2''
 
|Predictive for JAK2 inhibitors; Prognostic for PV  progression to MF
 
|Predictive for JAK2 inhibitors; Prognostic for PV  progression to MF
|[40, 44, 55, 56, 113]
+
|<ref name=":35">Rumi E, Harutyunyan A, Elena C, Pietra D, Klampfl T, Bagienski K, et al. Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm. Am J Hematol 2011;86:974-9.[https://www.ncbi.nlm.nih.gov/pubmed/21953568]</ref><ref name=":34" /><ref name=":35" />56, 113]
 
|-
 
|-
 
|
 
|
Line 166: Line 166:  
|
 
|
 
|Presence of CNAs/CN-LOH prognostic for progression to AML
 
|Presence of CNAs/CN-LOH prognostic for progression to AML
|[40, 55, 56<ref name=":6" />
+
|<ref name=":35" /><ref name=":35" />56<ref name=":6" />
 
|-
 
|-
 
|
 
|
Line 173: Line 173:  
|
 
|
 
|Recurrent
 
|Recurrent
|[40, 55, 114]
+
|<ref name=":35" />114]
 
|-
 
|-
 
|CML
 
|CML
Line 621: Line 621:  
|P  (Intermediate)
 
|P  (Intermediate)
 
|1
 
|1
|[23, 28<ref name=":20" />44, 56<ref name=":21" />
+
|[23, 28<ref name=":20" /><ref name=":34" />56<ref name=":21" />
 
|-
 
|-
 
|7
 
|7
Line 630: Line 630:  
|P (Poor)
 
|P (Poor)
 
|1
 
|1
|<ref name=":13" />44]
+
|<ref name=":13" /><ref name=":34" />
 
|-
 
|-
 
|7
 
|7
Line 684: Line 684:  
|P  (Intermediate)
 
|P  (Intermediate)
 
|1
 
|1
|[44, 56]
+
|<ref name=":34" />56]
 
|-
 
|-
 
|14
 
|14
Line 711: Line 711:  
|P  (Intermediate)
 
|P  (Intermediate)
 
|2
 
|2
|[44]
+
|<ref name=":34" />
 
|-
 
|-
 
|21
 
|21
Line 751: Line 751:  
|Recurrent
 
|Recurrent
 
|2
 
|2
|[40]
+
|<ref name=":35" />
 
|-
 
|-
 
|1
 
|1
Line 760: Line 760:  
|Recurrent
 
|Recurrent
 
|2
 
|2
|[40, 55, 56]
+
|<ref name=":35" /><ref name=":35" />56]
 
|-
 
|-
 
|4
 
|4
Line 796: Line 796:  
|P (Poor)
 
|P (Poor)
 
|1
 
|1
|[40]
+
|<ref name=":35" />
 
|-
 
|-
 
|7
 
|7
Line 823: Line 823:  
|Recurrent
 
|Recurrent
 
|2
 
|2
|[40, 55, 56]
+
|<ref name=":35" /><ref name=":35" />56]
 
|-
 
|-
 
|9
 
|9
Line 832: Line 832:  
|Recurrent
 
|Recurrent
 
|2
 
|2
|[40, 44]  [55] [56, 113]
+
|<ref name=":35" /><ref name=":34" /><ref name=":35" />56, 113]
 
|-
 
|-
 
|9
 
|9
Line 859: Line 859:  
|Recurrent
 
|Recurrent
 
|2
 
|2
|[40, 55]
+
|<ref name=":35" /><ref name=":35" />
 
|-
 
|-
 
|12
 
|12
Line 877: Line 877:  
|Recurrent
 
|Recurrent
 
|1
 
|1
|[55]
+
|<ref name=":35" />
 
|-
 
|-
 
|14
 
|14
Line 886: Line 886:  
|Recurrent
 
|Recurrent
 
|3
 
|3
|[40, 55, 56<ref name=":6" />
+
|<ref name=":35" /><ref name=":35" />56<ref name=":6" />
 
|-
 
|-
 
|17
 
|17
Line 895: Line 895:  
|P (Poor)
 
|P (Poor)
 
|1
 
|1
|[51, 52, 55]
+
|[51, 52<ref name=":35" />
 
|-
 
|-
 
|20
 
|20
Line 904: Line 904:  
|Recurrent
 
|Recurrent
 
|1
 
|1
|[40, 55, 114]
+
|<ref name=":35" />114]
 
|-
 
|-
 
|22
 
|22
43

edits